Doroszkiewicz, J.; Kulczyńska-Przybik, A.; Dulewicz, M.; Borawska, R.; Zajkowska, M.; Słowik, A.; Mroczko, B.
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease. J. Clin. Med. 2023, 12, 4689.
https://doi.org/10.3390/jcm12144689
AMA Style
Doroszkiewicz J, Kulczyńska-Przybik A, Dulewicz M, Borawska R, Zajkowska M, Słowik A, Mroczko B.
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Clinical Medicine. 2023; 12(14):4689.
https://doi.org/10.3390/jcm12144689
Chicago/Turabian Style
Doroszkiewicz, Julia, Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Renata Borawska, Monika Zajkowska, Agnieszka Słowik, and Barbara Mroczko.
2023. "Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease" Journal of Clinical Medicine 12, no. 14: 4689.
https://doi.org/10.3390/jcm12144689
APA Style
Doroszkiewicz, J., Kulczyńska-Przybik, A., Dulewicz, M., Borawska, R., Zajkowska, M., Słowik, A., & Mroczko, B.
(2023). Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Clinical Medicine, 12(14), 4689.
https://doi.org/10.3390/jcm12144689
